Business
See the "Notes to Consolidated Financial Statements" section of this Form 10-K for financial information about our business segments and international operations.
NEOGEN CORP: Revenue declined 3.2% to $895M from $924M. Net loss widened to $1.092B from $9.421M. Free-cash outflow narrowed to $46.35M from $76.16M. Operating margin contracted 12494 bps to -118.59%. NEOGEN CORP's annual comparison also shows stock compensation grew faster than revenue; inventory grew faster than revenue; the balance-sheet screen falls in the distress range and requires business-model context.
The read at a glance✓ Audited against SEC data
- Growth — Revenue declined 3.2% to $895M from $924MWatch
- Profitability — Net loss widened to $1.092B from $9.421MWatch
- Cash flow — Free-cash outflow narrowed to $46.35M from $76.16MOK
- Margins — Operating margin contracted 12494 bps to -118.59%Watch
- Accounting — Controls ineffective; material weaknessesWatch
- Insiders — 5 purchases and 0 salesOK
Where the revenue comes from
Fiscal 2026, as NEOGEN CORP reports it. History and quarterly detail are in the app.
- Food Safety$641.1M
- Animal Safety$229.3M
Leadership changes
From NEOGEN CORP's own filings, the day they're filed.
- Amy Rocklin · Chief Legal and Administrative Officer · departureeff. 2026-03-31
- Avi Pelossof · director · appointmenteff. 2025-10-24
- William T. Boehm · Directors · departureeff. 2025-08-11
Latest filings
- 8-K · Company announcement2026-08-07
- 8-K · Company announcement2026-07-30
- 10-K · Annual report2026-07-30
- 8-K · Company announcement2026-04-20
- 10-Q · Quarterly report2026-04-09
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about NEOGEN CORP, every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.